Search Orphan Drug Designations and Approvals
-
Generic Name: | Dehydroepiandrosterone |
---|---|
Date Designated: | 07/13/1994 |
Orphan Designation: | Treatment of systemic lupus erythematosus (SLE) and the reduction in the use of steroids in steroid-dependent SLE patients. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
GlaxoSmithKline P. O. Box 13398 Five Moore Drive Research Triangle Park, North Carolina 27709 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-